Stridex Liquid
NDC Package 10157-1007-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Stridex (salicylic acid) liquids is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a liquid delivery system. Marketed by Blistex Inc, this product is identified by NDC 10157-1007 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
10157-1007-2
Package Description
1 JAR in 1 CARTON / 70 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR
Product Code
10157-1007
11-Digit Billing Format
10157100702
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Stridex Sensitive
Non-Proprietary Name
Salicylic Acid
Substance Name
Salicylic Acid
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
SALICYLIC ACID .5 g/100mL
Usage Information
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

Regulatory & Marketing

Labeler Name
Blistex Inc
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10157-1007). Click a package code to view its specific billing and regulatory data.

10157-1007-1
1 JAR in 1 CARTON / 55 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR
10157-1007-3
1 JAR in 1 CARTON / 90 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR
10157-1007-4
1 JAR in 1 CARTON / 110 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10157-1007-2 identifies a specific commercial package of 1 jar in 1 carton / 70 applicator in 1 jar / 2 ml in 1 applicator of Stridex Sensitive, a human over the counter drug labeled by Blistex Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This liquid is formulated for topical use and contains salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc on December 01, 2012. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

How is this Blistex Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157100702. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
10157-1007-2
11-Digit CMS (5-4-2)
10157-1007-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.